Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. It is developing a ...
MCLEAN, Va.--(BUSINESS WIRE)--Delta Tucker Holdings, Inc. (“Holdings”), the parent of DynCorp International Inc. (“DI,” and together with Holdings, the “Company”), a leading global services provider, ...
TipRanks on MSN
Dyne Therapeutics appoints Vikram Karnani to board
Dyne Therapeutics ( ($DYN) ) has provided an update. On December 22, 2025, Dyne Therapeutics, Inc.’s board of directors elected Vikram Karnani as ...
Dyne Therapeutics, Inc. develops treatments for muscle diseases using its FORCE platform, with promising candidates DYNE-101 and DYNE-251 targeting DM1 and DMD, respectively. DYNE-251 shows ...
MCLEAN, Va.--(BUSINESS WIRE)--DynCorp International Inc.'s parent, Delta Tucker Holdings, Inc., will host a conference call at 10:00 a.m. Eastern Time on Tuesday, March 19, 2019, to discuss results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback